China's reform of the regulatory system for medical products and its impact
Natl Sci Rev
.
2019 Jan;6(1):1.
doi: 10.1093/nsr/nwz001.
Epub 2019 Feb 25.
Authors
Ruilin Song
1
2
,
Guowei Sang
1
,
Meiyu Geng
3
,
Hualiang Jiang
3
Affiliations
1
Research Center of National Drug Policy and Ecosystem, China Pharmaceutical University, China.
2
China Pharmaceutical Innovation and Research Development Association, China.
3
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
PMID:
34691816
PMCID:
PMC8291605
DOI:
10.1093/nsr/nwz001
No abstract available
Publication types
Editorial